Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Immune Oncology Research Institute
Aug 2, 2024, 09:31 | Dialogues
Chinese Cancer Drug Set to Transform Global Market: Glecirasib | Most Promising Cancer Drugs 2024
In this exclusive interview with Dr. Andrea Wang-Gillam, we discuss the revolutionary potential of Glecirasib…
Aug 1, 2024, 16:17 | Blog
Gevorg Tamamyan: OncoDaily Party Barcelona during the ESMO 2024
Gevorg Tamamyan shared a post on LinkedIn: "Who is coming to ESMO 2024? OncoDaily Party…
Jul 31, 2024, 00:39 | Dialogues
Life, Career, Leadership and Success - Dr. Clifford Hudis, CEO of ASCO
Dr. Clifford A. Hudis, CEO of the American Society of Clinical Oncology (ASCO), joins us…
Jul 30, 2024, 15:22 | Blog
Gevorg Tamamyan: Part of our big OncoDaily family
Gevorg Tamamyan shared on LinkedIn: "Part of our big OncoDaily family. Proud to be in such…
Jul 29, 2024, 10:25 | Blog
Gevorg Tamamyan: The most important thing about OncoDaily
Gevorg Tamamyan shared a post on LinkedIn: ''A few days ago, I discovered something important…
Jul 24, 2024, 08:09 | Blog
Gevorg Tamamyan: I urge Agenus to consider Armenia as the first country to register BOT/BAL combination
Gevorg Tamamyan shared on LinkedIn: "As I mentioned in my earlier post, we are ready in…
Jul 19, 2024, 10:46 | Blog
The first episode of OncoDaily Podcast is out!
We are thrilled to announce the launch of the first episode of the OncoDaily Podcast…
Jul 13, 2024, 14:25 | OncoDaily Pulse
OncoDaily Magazine - Inaugural Issue
We are excited to announce that the Inaugural issue of OncoDaily Magazine was launched on…
Jul 13, 2024, 14:15 | Dialogues
I never knew how close to this disease I would eventually become - Benny Johnson’s personal story with cancer
The new issue of OncoDaily Magazine had the privilege to feature an exclusive interview with Dr.…
Jul 5, 2024, 15:53 | Drugs
Gevorg Tamamyan: Waiting to see promising bot/bal results from our lung cancer trial
Gevorg Tamamyan posted on LinkedIn: "Just saw the presentation from ESMO GI Annual Congress and the…
All: 219 Posts: 61 - 70
Special Coverage